DOCSLIB.ORG

Last Name First Name Title Work Place Email Country

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Last First Title Work place Email Country name name 1 Aamdal Steinar Proferssor Oslo University Hospital [email protected] Norway 2 Aasland Rein Professor, instituttleder University of Bergen [email protected] Norway 3 Albrechtsen Susanne Clinic chief physician Haukeland University susanne.albrechtsen@helse- Norway Hospital bergen.no 4 Andersson Jan research director Stockholm County Council [email protected] Sweden 5 Andreassen Alf Henrik Executive medical Haukeland University [email protected] Norway director Hospital 6 Aropuu Sakari Country Head, Global Bayer Oy [email protected] Finland Site Management Finland 7 Athlin Åsa Head of Research Uppsala University Hospital [email protected] Sweden Muntlin 8 Bengtström Mia Senior Advisor Pharma Industry Finland [email protected] Finland 9 Bergquist Helene Head of Unit/Legal Karolinska Trial Alliance helene.bergquist- Sweden Frederiksen Counsel Support [email protected] 10 Berland Astrid Dosent Høgskolen [email protected] Norway Stord/Haugesund 11 Berndtson Ewa Clinicall Operations AbbVie AB [email protected] Sweden Manager 12 Bjerknes Robert Professor University of Bergen, [email protected] Norway Faculty of Medicine and Dentistry 13 Bjordal Kristin Head of Research Oslo University Hospital, [email protected] Norway Support Service, University of Oslo Professor UiO 14 Blom Øyvind Advisor Haukeland University [email protected] Norway Hospital 15 Bredmose Jesper R&I Consultant & Aalborg University Hospital [email protected] Denmark Program Coordinator 16 Brummer Robert Dean Örebro University [email protected] Sweden 17 Bryne Katrine MSc in Medical Science LMI [email protected] Norway 18 Calov Charlotte Head of the GCP Unit Odense University Hospital [email protected] Denmark 19 Carlson Erlend Clinical Contract Inven2 AS [email protected] Norway Manager 20 Christiansen Per CEO Rigshospitalet Copenhagen [email protected] Denmark 21 Colban Martha Clinical research Oslo University Hospital [email protected] Norway support 22 Dale Ola Professor St. Olavs University Hospital [email protected] Norway 23 Daphu Inderjit PhD Haukeland University inderjit.kaur.daphu@helse- Norway Hospital bergen.no 24 Engelstad Maiken Assistant Director Norwegian Ministry of [email protected] Norway General Health and Care Services 25 Englund Maria Director KTA Karolinska Trial Alliance [email protected] Sweden 26 Erikstein Bjørn CEO Oslo University Hospital [email protected] Norway 27 Finnes Ingvill Research coordinator St. Olavs Hospital [email protected] Norway Langgård 28 Flannick Jason Post doc Broad Institute of Harvard [email protected]' USA and MIT 29 Flølo Tone Reseach Nurse Voss Hospital [email protected] Norway Nygaard 30 Forss Mikael Deputy CEO Karolinska University [email protected] Sweden Hospital 31 Garnes Ingrid Head og gyn/obst dep Haukeland University ingrid.johanne.garnes@helse- Norway Johanne Hospital bergen.no 32 Geertsen Anders Head of Department Nordic Council of Ministers [email protected] Norway 33 Georgieva- Krastina Business Analyst BTO [email protected] Norway Ilkova 34 Gottfredsson Magnus Head of Research Landspitali, National [email protected] Iceland Governance University Hospital of Department Iceland 35 Grant Sally Daily leader Odense University Hospital [email protected] Denmark 36 Groop Leif Head of Department of Lund University [email protected] Sweden Clinical Sciences 37 Gunnarsson Anna- Mrs Uppsala University Hospital anna- Sweden Karin [email protected] 38 Gustafsson Annika Head of Section UNN [email protected] Norway 39 Hammer Marthe Special Adviser Haukeland University [email protected] Norway Hospital 40 Hansen Birgitte GCP-coordinator Bispebjerg Hospital [email protected] Denmark Vilsbøll 41 Hansen Eivind CFO Haukeland University [email protected] Norway Hospital 42 Heimdal John- Clinic Director Haukeland University [email protected] Norway Helge Hospital 43 Hjelmquist Erland Professor, Department University of Gothenburg [email protected] Sweden of Psychology 44 Holm Anne Lise Professor Høgskolen [email protected] Norway Stord/Haugesund 45 Huovinen Pentti Dean, Professor University of Turku, Medical [email protected] Finland Faculty 46 Høgli Mona Communications Haukeland University [email protected] Norway Director Hospital 47 Hølge- Bibi Director of Research Roskilde-Køge Hospital [email protected] Denmark Hazelton 48 Ingebrigtsen Tor CEO University Hospital of North [email protected] Norway Norway 49 Instefjord Hans Olav Director Haukeland University hans.olav.instefjord@helse- Norway Hospita bergen.no 50 Iversen Valentina 1.amanuensis/ECRIN St. Olavs University Hospital [email protected] Norway Cabral correspondent 51 Jangland Eva Senior lecturer Uppsala University [email protected] Sweden 52 Johnsen Ellen Ms Oslo University Hospital [email protected] Norway 53 Johnsen Lisbeth Coordinator clinical Akershus University [email protected] Norway trials Hospital 54 Jørgensen Annette Head of Department The GCP-unit at Aalborg [email protected] Denmark and Aarhus University Hospital 55 Jørgensen Lone PhD Student Clinical Nursing Research [email protected] Danmark Unit - Aalborg University Hospital 56 Kibuuka Moses Dr Saint Luke Hospoital [email protected] Uganda 57 Kolle Siri Vice President Clinical Invent2 [email protected] Norway 58 Kusk Kahtrine Clinical Nursing Aalborg University Hospital [email protected] Denmark Hoffmann Research Unit 59 Kvernmo Nils CEO St. Olavs University Hospital [email protected] Norway 60 Kvinnsland Stener CEO Haukeland University [email protected] Norway Hospital 61 Laastad Christina Project Manager Bergen Technology [email protected] Norway Transfer Office 62 Langberg Nina Head of Unit Oslo univeristy [email protected] Norway Borthen hospital/Radium hospital 63 Langeland Nina Dean Det medisinsk- odontologisk [email protected] Norway fakultet, UiB 64 Larsson Jörgen Professor of Surgery Karolinska University [email protected] Sweden and Director Hospital International Affairs 65 Laursen Birgitte Senior Researcher Clinical Nursing Research [email protected] Denmark Schantz Unit - Aalborg University Hospital 66 Lepola Pirkko Executive Secretary Clinical Research Institute [email protected] Finland FINPEDMED Helsinki University Central Hospital Ltd. 67 Liliebladh Lena Clinical Trial Manager FoU-centrum Skåne [email protected] Sweden 68 Linden Aki CEO Hospital District of Helsinki [email protected] Finland and Uusimaa 69 Lode Kirsten RN Phd Stavanger Univresity [email protected] Norway Hospital 70 Ludvigsen Janne Head of Section University Hospital of North [email protected] Norway Norway 71 Ludvigsen Mette Senior Researcher Randers Regional Hospital, [email protected] Denmark Spliid Clinical Research Unit 72 Lund Hanne Clinical Research MSD [email protected] Norway Wessel Manager 73 Magnusson Magnus Dean, Professor University of Iceland, [email protected] Iceland Karl Faculty of Medicine 74 Mark Edith Post. Doc. in clinical Aalborg University Hospital [email protected] Denmark nursing 75 Mary Ann Dr Saint Luke Hospoital [email protected] Uganda 76 Matthiasson Pall CEO Landspitali, National [email protected] Iceland University Hospital of Iceland 77 Mellgren Gunnar Director, Professor Laboratory Medicine and [email protected] Norway Pathology, Haukeland University Hospital 78 Mevold Nina Municipal Director Municipality of Bergen [email protected] Norway 79 Mjanger Guro Head of Section Centre for Health Research [email protected] Norway 80 Molven Anders Professor Department of Clinical [email protected] Norway Medicine, University of Bergen 81 Mortensen Bettina Coordinator - One Aalborg University Hospital [email protected] Denmark Entrance for Industry North 82 Mugiiza Sarah Dr Saint Luke Hospoital [email protected] Uganda 83 Møller Eva Senior advisor Haukeland University [email protected] Norway Hospital 84 Mølsæter Katarina Spesialrådgiver Helse Møre og Romsdal HF [email protected] Norway 85 Mørkved Siv Head of Reseach, St.Olavs Hospital [email protected] Norway Professor 86 Nedrebø Bente Head of System Haukeland University [email protected] Norway Administrators Hospital 87 Nesje Lars Clinical director / Haukeland University [email protected] Norway Birger professor Hospital 88 Nielsen Lars Bo Professor Department of Clinical [email protected] Denmark Medicine, University of CPH 89 Nikkari Seppo Vice Dean School of Medicine, [email protected] Finland University of Tampere 90 Njølstad Pål Head of the KG Jebsen KG Jebsen center for [email protected] Norway Rasmus center for Diabetes Diabetes research research 91 Nordgreen Tine PhD eMeistring [email protected] Norway 92 Nordheim Ole Professor Department University of Bergen [email protected] Norway Fridtjof of Global Public Health and Primary Care 93 Nordli Håkon Head of Clinic Helse Bergen HF [email protected] Norway 94 Nortvedt Ragnar Professor / Program MedViz, Haukeland [email protected] Norway Manager University Hospital 95 Nybond Lena Research Manager TurkuCRC [email protected] Finland 96 O'Dwyer Gerry President The European Association [email protected] United of Hospital Managers
Recommended publications
  • Annual Report Research Activity 2019

    Annual Report Research Activity 2019

    Annual Report Research Activity 2019 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo .................................................................................... 4 From Division Director Eva Bjørstad ........................................................................................................... 4 Division of Clinical Neuroscience (NVR) Organizational Chart ..................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma....................................................................................................................... 6 Group Leader: Nada Andelic Painful musculoskeletal disorders .............................................................................................................. 9 Group Leader: Cecilie Røe Department of Refractory Epilepsy - National Centre for Epilepsy Complex epilepsy .................................................................................................................................... 11 Group Leader: Morten Lossius Department of Neurosurgery Neurovascular-Hydrocephalus Research Group ..................................................................................... 16 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................. 19 Group Leaders: Eirik Helseth and Torstein
  • Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in Covid-19 Patients: Results from the NOR-Solidarity Randomised Trial

    Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in Covid-19 Patients: Results from the NOR-Solidarity Randomised Trial

    Evaluation of remdesivir and hydroxychloroquine on viral clearance in Covid-19 patients: Results from the NOR-Solidarity Randomised Trial Andreas Barratt-Due1,2,9,*, Inge Christoffer Olsen3, Katerina Nezvalova Henriksen4,5, Trine Kåsine1,9, Fridtjof Lund-Johansen2,6, Hedda Hoel7,9,10, Aleksander Rygh Holten8,9, Anders Tveita11, Alexander Mathiessen12, Mette Haugli13, Ragnhild Eiken14, Anders Benjamin Kildal15, Åse Berg16, Asgeir Johannessen9,17, Lars Heggelund18,19, Tuva Børresdatter Dahl1,10, Karoline Hansen Skåra10, Pawel Mielnik20, Lan Ai Kieu Le21, Lars Thoresen22, Gernot Ernst23, Dag Arne Lihaug Hoff24, Hilde Skudal25, Bård Reiakvam Kittang26, Roy Bjørkholt Olsen27, Birgitte Tholin28, Carl Magnus Ystrøm29, Nina Vibeche Skei30, Trung Tran2, Susanne Dudman9,39, Jan Terje Andersen9,31, Raisa Hannula32, Olav Dalgard9,33, Ane-Kristine Finbråten7,34, Kristian Tonby9,35, Bjorn Blomberg36,37, Saad Aballi38, Cathrine Fladeby39, Anne Steffensen9, Fredrik Müller9,39, Anne Ma Dyrhol-Riise9,35, Marius Trøseid9,40 and Pål Aukrust9,10,40 on behalf of the NOR-Solidarity study group# 1Division of Critical Care and Emergencies, Oslo University Hospital, 0424 Oslo, Norway 2Division of laboratory Medicine, Dept. of Immunology, Oslo University Hospital, 0424 Oslo, Norway 3Department of Research Support for Clinical Trials, Oslo University Hospital, 0424 Oslo, Norway 4Department of Haematology, Oslo University Hospital, 0424 Oslo, Norway 5Hospital Pharmacies, South-Eastern Norway Enterprise, 0050 Oslo, Norway 6ImmunoLingo Covergence Centre, University
  • Faculty of Medicine

    Faculty of Medicine

    About the Faculty of Medicine, University of Oslo With approximately one third of all medical students in Norway and almost two thirds of all PhD candidates, the Faculty of Medicine at the University of Oslo (UiO) has an important responsi- bility for providing high standards of medical education and research. The Faculty also offers a wide range of research and studies within health-related topics such as health administration, international health and nutrition. Norway has a well developed public health care system, and our researchers co-operate with different governmental bodies to ensure and support high standards. FACULTY OF MEDICINE Founded in 1814, the Faculty of Medicine is one of eight faculties at UiO. With approximately PO BOX 1078 Blindern, 0316 Oslo, Norway 1500 employees, our most important tasks are education, research and dissemination of Sogn Arena, 2. etg, Klaus Torgårds vei 3 information. The faculty’s annual budget is approximately 1 billion NOK (162 million USD), out Tel: +47 22 84 53 10 - Fax: +47 22 84 53 01 of which more than 50% are generated through external funding. UiO Faculty of Medicine F FACTS AND FIGURES (2009) OTO : THE University of Oslo (founded 1811) A n 7 000 employees TØ n Yearly budget: appr. 5.5 billion NOK (900 million USD) NN E S n 28 000 students E N , O S Oslo University Hospital L O n 20 000 employees UN n Yearly budget: appr. 18 billion NOK (3 billion USD) IVER S n I More than 1.2 million patients treated each year T E tssyk Akershus University Hospital n 5 000 employees EH n US Yearly budget: appr.
  • Motivation Letter Oslo, May 27Th, 2021 Dear ESGO Colleagues, I Am Writing

    Motivation Letter Oslo, May 27Th, 2021 Dear ESGO Colleagues, I Am Writing

    Motivation letter Oslo, May 27th, 2021 Dear ESGO colleagues, I am writing to express my great interest in running for ESGO council. As an active member of the society for many years, I have enjoyed taking part in various meetings and educational activities both in-person and online, benefiting from the hard work and dedication of the ESGO leadership. To be a part of this leadership team would be very rewarding and a great honor. I currently have the privilege of holding the position of social media editor for the International Journal of Gynecological Cancer. In this role I have worked closely with editor in chief, Pedro Ramirez, and learned a great deal from him regarding academic leadership. I have initiated a virtual journal club, mentored editorial fellows and been able to grow the journals social media followers on Twitter from ca 100 to more than 3000 in two years. Through this experience I have also very much enjoyed collaborating with the ESGO office, and my fellow associate editors from ESGO. As a gynecologic oncologist at the Norwegian Radiumhospital my main focus is surgical treatment of gynecologic malignancies, both robotic surgery and radical cytoreductive procedures. Since my return from fellowship at MSKCC in 2015 I have taken on the lead of our Endometrial cancer and gyn sarcoma team, have been responsible for organizing the annual Tropé meeting on updates and controversies in gynecologic oncology with professor emeritus Claes Tropé, and more recently initiated a course in ovarian cancer surgery, this year in conjunction with ESGO. Thank you for the opportunity to apply for ESGO council.
  • ERJ-03448-2020.Shareable

    ERJ-03448-2020.Shareable

    ORIGINAL ARTICLE | INFECTION AND LUNG FUNCTION Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19 Tøri Vigeland Lerum1, Trond Mogens Aaløkken2,3, Eivind Brønstad4,5, Bernt Aarli6,7, Eirik Ikdahl8, Kristine Marie Aarberg Lund9, Michael T. Durheim3,10, Jezabel Rivero Rodriguez2, Carin Meltzer2, Kristian Tonby3,11, Knut Stavem 3,8,12, Ole Henning Skjønsberg1,3, Haseem Ashraf3,13,14 and Gunnar Einvik3,8,14 Affiliations: 1Dept of Pulmonary Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 2Dept of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway. 3Institute for Clinical Medicine, University of Oslo, Oslo, Norway. 4Thoracic Dept, St Olavs Hospital, Trondheim, Norway. 5Dept of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences NTNU, Trondheim, Norway. 6Dept of Thoracic Medicine, Haukeland University Hospital, Haukeland, Norway. 7Dept of Clinical Science, University of Bergen, Bergen, Norway. 8Pulmonary Dept, Akershus University Hospital, Lørenskog, Norway. 9Dept of Infectious Diseases, Østfold Hospital Trust Kalnes, Grålum, Norway. 10Dept of Respiratory Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway. 11Dept of Infectious Diseases, Oslo University Hospital Ullevål, Oslo, Norway. 12Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway. 13Dept of Diagnostic Imaging, Akershus University Hospital, Lørenskog, Norway. 14Shared last authors. Correspondence: Gunnar Einvik, Pulmonary Dept, Akershus University Hospital, 1470 Lørenskog, Norway. E-mail [email protected] @ERSpublications 3 months after discharge, a quarter of COVID-19 survivors have reduced gas diffusion capacity and persistent parenchymal opacities. ICU treatment is associated with persistent parenchymal opacities, but not with dyspnoea or reduced diffusing capacity. https://bit.ly/2J3xH4x Cite this article as: Lerum TV, Aaløkken TM, Brønstad E, et al.
  • Source-Level EEG and Graph Theory Reveal Widespread Functional Network Alterations in Focal Epilepsy

    Source-Level EEG and Graph Theory Reveal Widespread Functional Network Alterations in Focal Epilepsy

    medRxiv preprint doi: https://doi.org/10.1101/2020.12.17.20248426; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Title page Full title Source-level EEG and graph theory reveal widespread functional network alterations in focal epilepsy Authors and affiliations Christoffer Hatlestad-Hall1, Ricardo Bruña2,3,4, Marte Roa Syvertsen5, Aksel Erichsen1,6, Vebjørn Andersson1, Fabrizio Vecchio7, Francesca Miraglia7, Paolo M. Rossini7, Hanna Renvall8,9, Erik Taubøll1,10, Fernando Maestú2,3,4, and Ira H. Haraldsen1 1 Department of Neurology, Oslo University Hospital, Oslo, Norway 2 Center for Biomedical Technology, Technical University of Madrid, Pozuelo de Alarcón, Spain 3 Department of Experimental Psychology, Complutense University of Madrid, Pozuelo de Alarcón, Spain 4 Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain 5 Department of Neurology, Drammen Hospital, Vestre Viken Health Care Trust, Drammen, Norway 6 Department of Nuclear Medicine, Oslo University Hospital, Oslo, Norway 7 Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Pisana, Rome, Italy 8 Department of Neuroscience and Biomedical Engineering, Aalto University, Helsinki, Finland 9 BioMag Laboratory, HUS Medical Imaging Center, Helsinki University Hospital, Helsinki, Finland 10 Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway Correspondence to: Christoffer Hatlestad-Hall Department of Neurology, Oslo University Hospital, PO Box 4956 Nydalen, 0424 Oslo, Norway Email: [email protected] NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.
  • University of Oslo

    University of Oslo

    Now available at the Oslo Centre for Biostatistics and Epidemiology: A full time Researcher in biostatistics for clinical trials at Oslo University Hospital, possibly combined with a 20% Professor position at the University of Oslo. Oslo University Hospital (OUS), in partnership with the University of Oslo (UiO), is seeking outstanding, inspiring and enthusiastic candidates for a permanent position at the Oslo Centre for Biostatistics and Epidemiology (OCBE), Oslo, Norway. OCBE homepage: http://www.med.uio.no/imb/english/research/centres/ocbe/ We wish to recruit a biostatistician with strong competence in the methodology and practice of clinical trials, including complex designs and heterogeneous data. If the candidate is evaluated to have professor competence, then the position will be integrated with a 20% professor position at the Institute of Basic Medical Sciences, the Faculty of Medicine, UiO, Norway. This is an opportunity to join one of Europe's most active biostatistics groups at an exciting time. OCBE has staff affiliated with both OUS, in the department of Research Support Services, and UiO, in the Institute of Basic Medical Sciences. Currently, the centre includes seven tenured professors, four associate professors, fourteen researchers, and several post-doctoral fellows and PhD students, making up a group of about 55. OCBE is internationally recognized, with interests spanning a broad range of areas (including time-to-event models, data integration, causal inference, statistical genomics, Bayesian inference, Machine Learning, informative missingness and measurement error models, epidemiological studies of lifestyle and chronic diseases, stochastic models for infectious diseases, high dimensional data and models, clinical trials, register based studies) and numerous collaborations with a number of leading bio-medical research groups in Norway and internationally.
  • Professor Dr. Per Brandtzaeg

    Professor Dr. Per Brandtzaeg

    December 2015 Professor Dr. Per Brandtzaeg Per BRANDTZAEG LIIPAT, Department of Pathology Oslo University Hospital, Rikshospitalet P.O. Box 4950 Nydalen 0424 Oslo, Norway Tel: 47-23 07 27 43 Fax: 47-23 07 15 11 E-mail: [email protected] Biographical Sketch Professor Per Brandtzaeg obtained his postgraduate training in microbiology, immunology and pathology at the Medical Center, Univ. of Alabama at Birmingham, AL, USA (1962-64) and received his PhD in immunology at the Univ. of Oslo (1971). He is the former Head of the Faculty Division, Rikshospitalet University Hospital, Oslo, and the founder (1965) of the Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), Institute and Department of Pathology, which is devoted to research on mucosal immunity. He is also the founder (2001) of a thematic research network called the Center for Vaccinology and Immunotherapy (CEVI) at the University of Oslo, with a focus on basic mechanisms of importance for active and passive immunization. In 2007, CEVI obtained status as a Center of Excellence funded by the Research Council of Norway. Professor Brandtzaeg’s main research interest is in the immunobiology and immunopathology of mucous membranes. He obtained the top score of leading European scientists in the field of mucosal immunology in a worldwide peer judgement carried out by the US National Academy of Sciences Immunology Benchmarking Panel in 1998, and has been one of Norway’s most cited researchers over the last two decades. He has received several major national and international science awards, and is Commander of the Royal Norwegian Order of St. Olav. Brief Curriculum Vitae Personal data Born 9 June 1936 in Bergen, Norway.
  • ANNUAL REPORT 2018 3 Introduction by the Director

    ANNUAL REPORT 2018 3 Introduction by the Director

    Oslo University Hospital The Norwegian Radium Hospital INSTITUTE Institute for Cancer Research FORINSTITUTE CANCER Ullernchausseen 70 RESEARCH N–0379 Oslo FOR CANCER Norway P.O. BOX 4953 Nydalen RESEARCH N–0424 Oslo Norway ANNUAL http://ous-research.no/institute/ REPORTAnnual 201Report7 INSTITUTE FOR CANCER RESEARCH CANCER FOR INSTITUTE 2018 ANNUAL REPORT 2017 REPORT ANNUAL Contents 4 Introduction by the Director 6 The Institute for Cancer Research into the future 8 Organisation and key figures 12 Oslo University Hospital Comprehensive Cancer Centre 14 Departments and research groups 16 Cancer Genetics 22 Cancer Immunology EDITORIAL STAFF: 30 Molecular Cell Biology Kjetil Taskén Gunhild M. Mælandsmo 36 Molecular Oncology Peter Wiedswang Kari Aalrust Berger 42 Radiation Biology 48 Tumor Biology DESIGN: Espen Liland 54 Core Facilities PHOTOGRAPHY: Terje Heiestad The photographic theme of this year’s Annual Report is Humans at ICR. - The most important part of ICR is 58 Research centres by far its human resources and our collective competence. 60 Centre of Excellence 62 K. G. Jebsen Centres FRONT PAGE: Light, protons and neutrons are utilised 68 Norwegian Cancer Genomics Consortium to activate photosensitizers for cancer therapy. This is funded by two new EU Horizon2020 Future Emerging Technologies (FET-OPEN) grants to 70 International Collaboration Department of Radiation Biology (Theo Theodossiou and Kristian Berg) along 72 Recent Innovations with support from HSØ. Here: Diode 74 Publications laser-based PCI treatment. PAPER: 150/300 Profimatt CIRCULATION: 800 INSTITUTE FOR CANCER RESEARCH | ANNUAL REPORT 2018 3 Introduction by the Director The Institute for Cancer Research (ICR) is an Society to Vessela Kristensen, the award of the UiO institution with approximately 350 employees Research Prize to Harald Stenmark, the Ragnar Mørk’s plus students organised in 24 research groups Prize for Outstanding Research to Kaisa Haglund and complemented with cutting-edge core facilities.
  • Supplementary Material Evidence for Widespread Alterations in Cortical

    Supplementary Material Evidence for Widespread Alterations in Cortical

    Supplementary Material Evidence for widespread alterations in cortical microstructure after 32 hours of sleep deprivation Authors: Irene Voldsbekka,b,c,*, Atle Bjørnerud a,c,d, Inge Grootec, Nathalia Zak b,f, Daniel Roelfs b,g, Ivan I. Maximov a,b,h, Oliver Geier f, Paulina Due-Tønnesseni, Erlend Bøenj, Yvonne S. Kuiperf, Lise-Linn Løkkenf, Marie Strømstada, Taran Y. Blakstvedta, Bjørn Bjorvatnk,l, Ulrik F. Maltg, Lars T. Westlyea,b,m, Torbjørn Elvsåshagen b,g,n, Håkon Grydelanda,o,* a Department of Psychology, University of Oslo, Oslo, Norway. b Norwegian Centre for Mental Disorders Research (NORMENT), Oslo University Hospital, Oslo, Norway. c Computational Radiology and Artificial Intelligence (CRAI), Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. d Department of Physics, University of Oslo, Oslo, Norway. e Department of Radiology, Vestfold Hospital Trust, Tønsberg, Norway. f Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. g Institute of Clinical Medicine, University of Oslo, Oslo, Norway. h Department of Health and Functioning, Western Norway University of Applied Sciences, Bergen, Norway. i Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. j Psychosomatic and CL Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. k Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. l Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway. m KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway. n Department of Neurology, Oslo University Hospital, Oslo, Norway. o Center for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway.
  • FULLTEXT02.Pdf

    FULLTEXT02.Pdf

    http://www.diva-portal.org This is the published version of a chapter published in Via Spatiosa: Festschrift to Ragnar Andersson on his 67th birthday. Citation for the original published chapter: Englund, L. (2014) The bomb attack in Oslo and the shootings at Utøya, Norway, 2011: Experiences of communication and media management. In: S. Mooniruzzaman, F. Nilson & E. Svensson (ed.), Via Spatiosa: Festschrift to Ragnar Andersson on his 67th birthday (pp. 55-67). Karlstad: Karlstad University Press N.B. When citing this work, cite the original published chapter. Permanent link to this version: http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-34861 The bomb attack in Oslo and the shootings at Utøya, Norway, 2011 The bomb attack in Oslo and the shootings at Utøya, Norway, 2011 Experiences of communication and media management Liselotte Englund Communities and authorities need to be well prepared for communication and media management in the presence of current, emerging or evolving risks. The conception of risk usually overlaps with definitions on crises and disasters. Risk communication is often used broadly to capture both risk and crisis communica- tion. Crisis communication, often conflated with risk communication, is a sepa- rate field, but can include aspects of risk communication (Sheppard et al, 2012). Historically, risk communication research tends to most frequently involve case studies and lists of best practices. Among earlier case studies are the Septem- ber 11th terrorist attacks (Carey, 2003, in Noll) and Hurricane Katrina (Sheppard et al, 2012). Risk communication studies have a tradition of focusing on informa- tion presentation, persuasion, and strategic messaging.
  • Annual Report Research Activity 2018

    Annual Report Research Activity 2018

    Annual Report Research Activity 2018 Division of Clinical Neuroscience University of Oslo and Oslo University Hospital 0 Contents Oslo University Hospital and the University of Oslo ................................................................................... 4 From Division Director Eva Bjørstad ........................................................................................................... 4 Division of Clinical Neuroscience (NVR) Organizational Chart ................................................................... 5 Department of Physical Medicine and Rehabilitation Rehabilitation after trauma ........................................................................................................................ 6 Group Leader: Nada Andelic Painful musculoskeletal disorders ............................................................................................................ 10 Group Leader: Cecilie Røe Department of Refractory Epilepsy – National Centre for Epilepsy Complex epilepsy ...................................................................................................................................... 11 Group Leader: Morten Lossius Department for Neurosurgery Neurovascular-Hydrocephalus Research Group .................................................................................... 15 Group Leader: Per Kristian Eide Oslo Neurosurgical Outcome Study Group (ONOSG) ................................................................................ 18 Group Leader: Eirik Helseth and Torstein Meling